Neurotrophic KeratitisSymptoms, Doctors, Treatments, Advances & More
Learn About Neurotrophic Keratitis
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Baylor College Of Medicine - Ophthalmology
Stephen Pflugfelder, MD, is dedicated to delivering high-quality, compassionate care to Houston and nearby communities. Stephen Pflugfelder specializes in Ophthalmology (Eye) and works at BCM Ophthalmology. To make an appointment, please call (713) 798-6100. To review all accepted insurance carriers, please visit: https://www.stlukeshealth.org/patients-visitors/patients/billing-insurance/insurances-accepted. Dr. Pflugfelder is rated as an Elite provider by MediFind in the treatment of Neurotrophic Keratitis. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Interstitial Keratitis, Dry Eye Syndrome, Giant Papillary Conjunctivitis, Conjunctivitis (Pink Eye), and Corneal Transplant. Dr. Pflugfelder is currently accepting new patients.
Eye Consultants Of Pennsylvania PC
Kevin Shah is an Ophthalmologist practicing medicine in Wyomissing, Pennsylvania. Dr. Shah is rated as a Distinguished provider by MediFind in the treatment of Neurotrophic Keratitis. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Neurotrophic Keratitis, Cataract, Pterygium, and Interstitial Keratitis. Dr. Shah is board certified in American Board Of Ophthalmology.
Alessandro Lambiase practices practicing medicine in Rome, Italy. Mr. Lambiase is rated as an Elite expert by MediFind in the treatment of Neurotrophic Keratitis. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Neurotrophic Keratitis, Giant Papillary Conjunctivitis, Interstitial Keratitis, Vitrectomy, and Corneal Transplant.
Summary: This is a Phase II, double-blind, placebo-controlled study to evaluate the safety and efficacy of STSP-0902 ophthalmic solution in patients with neurotrophic keratitis (NK). The study plans to enroll 48 patients with Mackie Stage 2 or 3 NK affecting one or both eyes. Eligible subjects will be randomized 1:1:1 into three dosing groups. Each dosing group will follow a drug-placebo allocation (12 act...
Summary: The Sponsor is developing KB801, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector engineered to deliver functional full-length human nerve growth factor (NGF) to the corneas of people with Stage 2 or 3 neurotrophic keratitis (NK) via topical application. This is a Phase 1/2, multicenter, double-masked, placebo-controlled study to evaluate the safety, tole...